Evidence map›Paper›PMID 38360974›Full record

ArticleScientific reports2024

Predicting long-term time to cardiovascular incidents using myocardial perfusion imaging and deep convolutional neural networks.

Yi-Lian Li, Hsin-Bang Leu, Chien-Hsin Ting, Su-Shen Lim, Tsung-Ying Tsai, Cheng-Hsueh Wu, I-Fang Chung, Kung-Hao Liang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Cardiology-Chat: A Multi-LLMs Powered System for Cardiac Diagnostic Reasoning and Clinical Support.IEEE journal of translational engineering in health and medicine · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yi-Lian Li *Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei City, Taiwan.
Hsin-Bang Leu *Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Chien-Hsin TingDepartment of Nuclear Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Su-Shen LimDepartment of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Tsung-Ying TsaiDepartment of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Cheng-Hsueh WuDepartment of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
I-Fang ChungInstitute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei City, Taiwan. ifchung@nycu.edu.tw.
Kung-Hao LiangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei City, Taiwan. kunghao@gmail.com.
Taipei Veterans General Hospital · TWNational Yang Ming Chiao Tung University · TW

Funding

Ministry of Science and Technology, Taiwan MOST 110 2634 F A49 005Taipei Veterans General Hospital V113E-002-4
6 · The paper itself

Abstract

Myocardial perfusion imaging (MPI) is a clinical tool which can assess the heart's perfusion status, thereby revealing impairments in patients' cardiac function. Within the MPI modality, the acquired three-dimensional signals are typically represented as a sequence of two-dimensional grayscale tomographic images. Here, we proposed an end-to-end survival training approach for processing gray-scale MPI tomograms to generate a risk score which reflects subsequent time to cardiovascular incidents, including cardiovascular death, non-fatal myocardial infarction, and non-fatal ischemic stroke (collectively known as Major Adverse Cardiovascular Events; MACE) as well as Congestive Heart Failure (CHF). We recruited a total of 1928 patients who had undergone MPI followed by coronary interventions. Among them, 80% (n = 1540) were randomly reserved for the training and 5- fold cross-validation stage, while 20% (n = 388) were set aside for the testing stage. The end-to-end survival training can converge well in generating effective AI models via the fivefold cross-validation approach with 1540 patients. When a candidate model is evaluated using independent images, the model can stratify patients into below-median-risk (n = 194) and above-median-risk (n = 194) groups, the corresponding survival curves of the two groups have significant difference (P < 0.0001). We further stratify the above-median-risk group to the quartile 3 and 4 group (n = 97 each), and the three patient strata, referred to as the high, intermediate and low risk groups respectively, manifest statistically significant difference. Notably, the 5-year cardiovascular incident rate is less than 5% in the low-risk group (accounting for 50% of all patients), while the rate is nearly 40% in the high-risk group (accounting for 25% of all patients). Evaluation of patient subgroups revealed stronger effect size in patients with three blocked arteries (Hazard ratio [HR]: 18.377, 95% CI 3.719-90.801, p < 0.001), followed by those with two blocked vessels at HR 7.484 (95% CI 1.858-30.150; p = 0.005). Regarding stent placement, patients with a single stent displayed a HR of 4.410 (95% CI 1.399-13.904; p = 0.011). Patients with two stents show a HR of 10.699 (95% CI 2.262-50.601; p = 0.003), escalating notably to a HR of 57.446 (95% CI 1.922-1717.207; p = 0.019) for patients with three or more stents, indicating a substantial relationship between the disease severity and the predictive capability of the AI for subsequent cardiovascular inciidents. The success of the MPI AI model in stratifying patients into subgroups with distinct time-to-cardiovascular incidents demonstrated the feasibility of proposed end-to-end survival training approach.

Indexed as

Coronary Artery DiseaseMyocardial InfarctionMyocardial Perfusion ImagingHumansPrognosisProportional Hazards ModelsRisk FactorsTomography, Emission-Computed, Single-PhotonEnd-to-end survival trainingMultiresolutionRisk scoreSurvival analysis

Identifiers

PMID38360974
PMCPMC10869727
OpenAlexW4391843583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.